Stock ADPT ADAPTIVE BIOTECHNOLOGIES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Adaptive Biotechnologies Corporation

Equities

ADPT

US00650F1093

Market Closed - Nasdaq
Other stock markets
 21:00:01 01/05/2024 BST 		5-day change 1st Jan Change
2.78 USD +6.11% Intraday chart for Adaptive Biotechnologies Corporation +7.75% -43.27%
04-05 Adaptive Biotechnologies Corporation Announces Preliminary Unaudited Revenue Results for the First Quarter Ended March 31, 2024 CI
04-03 Adaptive Biotechnologies Corporation Announces CFO Changes CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Adaptive Biotechnologies Reports Preliminary Q1 Revenue, Appoints Kyle Piskel as CFO
Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024
Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down
Adaptive Biotechnologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Adaptive Biotechnologies Corporation and Collaborators to Present More Than 30 Abstracts Demonstrating the Actionability of ClonoSEQ MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th Annual Meeting
Las mejores acciones para ganar en bolsa en Wall Street en 2024
Adaptive Biotechnologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Adaptive Biotechnologies Corporation Updates Revenue Guidance for the Full Year 2023
Adaptive Biotechnologies Partners With BeiGene on Minimal Residual Disease Testing of Potential Treatments for Lymphoid Malignancies
Adaptive Biotechnologies Corporation Announces New Translational Collaboration to Measure Minimal Residual Disease with Clonoseq(R) Assay Across Beigene's Lymphoid Malignancy Pipeline
Adaptive Biotechnologies Corporation Announces Launch of Epic Integration for ClonosEQ
Adaptive Biotechnologies Corporation Announces Kevin Conroy Resigns from the Board
Insider Sell: Adaptive Biotechnologies
Adaptive Biotechnologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Adaptive Biotechnologies Corporation Announces Executive Changes
Insider Sell: Adaptive Biotechnologies
Insider Sell: Adaptive Biotechnologies
Adaptive Biotechnologies Corporation Announces Resignation of Leslie Trigg from the Board
Insider Sell: Adaptive Biotechnologies
Adaptive Biotechnologies Highlights New Data At ASCO 2023 and EHA 2023 Underscoring the Clonoseq® Assay's Impact as A Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADPT Stock
  4. News Adaptive Biotechnologies Corporation
  5. Other languages